PedAM
Pediatric Disease Annotations & Medicines
| Disease | diabetes mellitus, insulin-dependent |
| Symptom | C0022658|renal disease |
| Sentences | 17 |
| PubMedID- 24455393 | Simultaneous pancreas and kidney transplantation is the standard of care for type 1 diabetes mellitus (dm) with end-stage renal disease (esrd) with an increased frequency of exocrine enteric drainage 1. |
| PubMedID- 22937188 | type 1 diabetes mellitus or patients with liver, renal diseases and any other diseases that could affect the outcome of this study were excluded. |
| PubMedID- 21962117 | Association of genetic variants in the promoter region of genes encoding p22phox (cyba) and glutamate cysteine ligase catalytic subunit (gclc) and renal disease in patients with type 1 diabetes mellitus. |
| PubMedID- 23919599 | In conclusion, these heterogeneous results suggest that neither cybb nor gpx4 are major genetic determinants of diabetic nephropathy, but nevertheless, they could modulate in a gender-specific manner the risk for renal disease in patients with type 1 diabetes. |
| PubMedID- 22129915 | Simultaneous kidney and pancreas transplantation (spkt) has become an effective therapy for a selected group of patients with end stage renal disease due to type 1 diabetes mellitus. |
| PubMedID- 21526312 | Background: simultaneous kidney and pancreas transplantation (skpt) is the best alternative for end stage renal disease among patients with insulin dependent diabetes mellitus. |
| PubMedID- 22414297 | Conclusions: elevated pulse pressure independently predicts mortality, cardiovascular events and progression to end-stage renal disease in patients with type 1 diabetes. |
| PubMedID- 22341254 | Spk transplant is the definitive treatment of type 1 diabetes combined with end-stage renal disease. |
| PubMedID- 25720601 | Urinary adiponectin is an independent predictor of progression to end-stage renal disease in patients with type 1 diabetes and diabetic nephropathy. |
| PubMedID- 25757212 | Background: simultaneous kidney and pancreas (spk) transplantation is an attractive option for end-stage renal disease patients with type 1 diabetes. |
| PubMedID- 24663809 | Risk of renal disease in patients with both type 1 diabetes and coeliac disease. |
| PubMedID- 26216409 | These studies are most often cross-sectional in design and mainly focused on type 1 diabetes or patients with end stage renal disease. |
| PubMedID- 20424230 | Diabetic nephropathy is one of the most severe complications in patients with type 1 diabetes, leading to end-stage renal disease (esrd) and the need for renal replacement therapy (dialysis and transplantation). |
| PubMedID- 21168662 | Simultaneous kidney-pancreas transplantation for end-stage renal disease patients with insulin-dependent diabetes and detectable c-peptide. |
| PubMedID- 24675963 | A recent study addressing the association between sodium excretion, an important part of total urine osmolarity, and end-stage renal disease in patients with type 1 diabetes mellitus showed an inverse association with end stage renal disease . |
| PubMedID- 22314339 | Background: although combined pancreas and kidney transplantation is an established procedure for the treatment of type 1 diabetes (t1d) in patients with end-stage renal disease, the role of pancreas transplant alone (pta) in the therapy of t1d subjects with preserved kidney function is still matter of debate. |
| PubMedID- 25594654 | Patients who develop end-stage renal disease (esrd) associated with type i diabetes mellitus may receive kidney alone (ka) transplantation, simultaneous pancreas-kidney (spk) transplantation, or a pancreas after kidney (pak) transplantation. |
Page: 1